Page last updated: 2024-10-24

regulation of Notch signaling pathway

Definition

Target type: biologicalprocess

Any process that modulates the frequency, rate or extent of the Notch signaling pathway. [GOC:go_curators]

The Notch signaling pathway is a highly conserved cell-cell communication mechanism that plays crucial roles in various developmental processes, including cell fate determination, differentiation, proliferation, and apoptosis. It is initiated by the binding of a transmembrane ligand on one cell to its receptor, Notch, on an adjacent cell. This interaction triggers a series of proteolytic cleavages within the Notch receptor, ultimately releasing the Notch intracellular domain (NICD). NICD translocates to the nucleus, where it interacts with transcription factors, such as CSL (CBF1/RBP-Jk/Su(H)), to activate the transcription of target genes.

The regulation of Notch signaling pathway involves intricate mechanisms at multiple levels, ensuring precise control over its activation and duration.

**1. Ligand-Receptor Interaction:**
- The initiation of Notch signaling depends on the binding of a ligand to its receptor. There are four known Notch receptors (Notch1-4) and five known ligands (Jagged1/2 and Delta-like 1/3/4).
- The expression and availability of both ligands and receptors are tightly regulated, influencing the specificity and strength of signaling.
- Ligand binding to Notch receptor induces conformational changes, leading to the recruitment of the ADAM (a disintegrin and metalloproteinase) family of proteases.

**2. Proteolytic Cleavage and NICD Release:**
- ADAM proteases cleave Notch at the extracellular domain, releasing a fragment that remains attached to the cell surface.
- This fragment is then recognized by γ-secretase, an intramembrane-cleaving protease, which further cleaves Notch within the transmembrane domain.
- This cleavage event releases NICD from the membrane, allowing it to translocate to the nucleus.

**3. Nuclear Translocation and Target Gene Activation:**
- Once in the nucleus, NICD interacts with CSL, a DNA-binding protein.
- In the absence of NICD, CSL acts as a transcriptional repressor.
- NICD binding to CSL relieves repression and activates the transcription of target genes.
- The transcription of target genes is further modulated by other transcription factors, including Mastermind-like proteins (MAMLs), which interact with NICD-CSL complexes.

**4. Negative Regulation:**
- Notch signaling is subject to complex negative feedback mechanisms that prevent overactivation and ensure proper temporal control.
- These mechanisms involve several factors:
- **Endocytosis and Degradation of Notch Receptor:** Upon ligand binding, Notch receptor can be internalized and degraded, reducing its availability.
- **Ligand Shedding:** Ligands can be cleaved by proteases, decreasing their ability to bind to Notch receptors.
- **Suppression of NICD Activity:** Specific proteins, such as Numb and Deltex, can inhibit NICD activity and promote its degradation.
- **MicroRNAs:** Certain microRNAs can target Notch pathway components, regulating their expression and activity.

**5. Crosstalk with Other Signaling Pathways:**
- Notch signaling pathway does not operate in isolation and interacts with other signaling pathways, including Wnt, Hedgehog, and TGF-β.
- These interactions influence Notch activity and contribute to the complexity of its regulatory network.

**6. Developmental Roles of Notch Signaling:**
- Notch signaling plays essential roles in a wide range of developmental processes, including:
- **Cell Fate Determination:** Notch signaling regulates the differentiation of various cell types, including neurons, muscle cells, and blood cells.
- **Pattern Formation:** Notch signaling contributes to the establishment of proper spatial organization during development.
- **Organogenesis:** Notch signaling is involved in the formation of various organs, including the heart, lung, and liver.
- **Stem Cell Maintenance:** Notch signaling plays a role in regulating the self-renewal and differentiation of stem cells.

**7. Disease Relevance:**
- Dysregulation of Notch signaling has been implicated in various diseases, including:
- **Cancer:** Aberrant Notch activity can promote uncontrolled cell growth and tumor development.
- **Neurological Disorders:** Disruptions in Notch signaling have been linked to neurodevelopmental disorders and neurodegenerative diseases.
- **Immune Disorders:** Notch signaling plays a crucial role in immune cell development and function, and its dysregulation can contribute to immune system dysregulation.

In summary, the regulation of Notch signaling pathway is a highly complex and multifaceted process involving intricate interactions between ligands, receptors, proteases, transcription factors, and other signaling pathways. This precise regulation ensures the proper execution of Notch's diverse functions in development and disease.'
"

Proteins (2)

ProteinDefinitionTaxonomy
Sterol regulatory element-binding protein 2A sterol regulatory element-binding protein 2 that is encoded in the genome of human. [PRO:CNA, UniProtKB:Q12772]Homo sapiens (human)
Disintegrin and metalloproteinase domain-containing protein 10A disintegrin and metalloproteinase domain-containing protein 10 that is encoded in the genome of human. [PRO:WCB, UniProtKB:O14672]Homo sapiens (human)

Compounds (6)

CompoundDefinitionClassesRoles
25-hydroxycholesterol25-hydroxy steroid;
oxysterol
human metabolite
ilomastatCS 610: matrix metalloproteinase inhibitor; structure in first source

ilomastat : An N-acyl-amino acid obtained by formal condensation of the carboxy group of (2R)-2-[2-(hydroxyamino)-2-oxoethyl]-4-methylpentanoic acid with the amino group of N-methyl-L-tryptophanamide. A cell permeable broad-spectrum matrix metalloproteinase (MMP) inhibitor
hydroxamic acid;
L-tryptophan derivative;
N-acyl-amino acid
anti-inflammatory agent;
antibacterial agent;
antineoplastic agent;
EC 3.4.24.24 (gelatinase A) inhibitor;
neuroprotective agent
fatostatinfatostatin: inhibits activation of SREBP; structure in first sourcethiazoles
bms-566394BMS-566394: structure in first source
incb3619INCB3619: ADAM inhibitor; structure in first source
grassystatin agrassystatin A: isolated from a cyanobacterium, identified as Lyngbya cf.; structure in first source